Acetic Acid

Acetic Acid

SCHEMBL7233241

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].COc1ccc(O)c(-c2ccc(-c3ccc(-c4cc(OC)ccc4O)cn3)nc2)c1.[Mn+3]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.48
MEN1 O00255 6/20 0.48
NPC1 O15118 6/20 0.48
RAB9A P51151 6/20 0.48
GAA P10253 5/20 0.48
ALOX15 P16050 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 3/20 0.48
HPGD P15428 3/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
RXFP1 Q9HBX9 1/20 0.45
USP2 O75604 2/20 0.44
ALDH1A1 P00352 4/20 0.44
TSHR P16473 2/20 0.44
HTT P42858 1/20 0.44
NOD2 Q9HC29 1/20 0.44
CASP3 P42574 4/20 0.42
SENP7 Q9BQF6 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7235881 0.95 KMT2A (0.50) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7242221 0.94 KMT2A (0.51) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7243728 0.94 GAA (0.45) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7235306 0.93 KMT2A (0.46) KMT2AMEN1NPC1RAB9AGAA
Hydrochloric Acid SCHEMBL7234590 0.90 KMT2A (0.54) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7233760 0.89 GAA (0.44) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7235569 0.89 FYN (0.42) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7233180 0.89 GAA (0.40) KMT2AMEN1NPC1RAB9AGAA
Acetic Acid SCHEMBL7243726 0.88 KMT2A (0.42) KMT2AMEN1NPC1RAB9AGAA
Hydrochloric Acid SCHEMBL7238375 0.85 KMT2A (0.55) KMT2AMEN1NPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119573-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2001-08-01 EP claimed
US-6177419-B1 ANTIOXIDANT CHELATE COMPOUNDS FOR PREVENTING OXYGEN FREE RADICAL-ASSOCIATED DISEASES IN MAMMALS; NEUROPROTECTANTS, SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT) AND/OR PEROXIDASE (POD) MIMETICS EUKARION, INC. 2001-01-23 US claimed
WO-2000009512-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2000-02-24 WO claimed
US-6541490-B1 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt EUKARION, INC. 2003-04-01 US disclosed
EP-1119573-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2001-08-01 EP disclosed
US-6177419-B1 ANTIOXIDANT CHELATE COMPOUNDS FOR PREVENTING OXYGEN FREE RADICAL-ASSOCIATED DISEASES IN MAMMALS; NEUROPROTECTANTS, SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT) AND/OR PEROXIDASE (POD) MIMETICS EUKARION, INC. 2001-01-23 US disclosed
WO-2000009512-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2000-02-24 WO disclosed